MULTITUDE SE/ FI4000106299 /
2024-05-02 9:04:02 AM | Chg. +0.040 | Volume | Bid9:51:42 AM | Ask9:49:11 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
5.300EUR | +0.76% | 13 Turnover: 68.900 |
5.060Bid Size: 1,384 | 5.200Ask Size: 541 | 110.05 mill.EUR | 0.00% | 255.00 |
GlobeNewswire
7:00 AM
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resoluti...
GlobeNewswire
04-30
BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on ...
GlobeNewswire
04-30
EU Nephrologists Foresee Travere/CSL Vifor’s FILSPARITM (sparsentan) Transforming IgA Nephropathy Tr...
GlobeNewswire
04-30
AspireHR Launches ‘DiamondOps AMS’ for Increased Customer Value Through Innovative HR Technology Sup...
GlobeNewswire
04-30
Blue Mantis Expands Strategic Resource Management Portfolio to Meet Ever-Increasing Client Demand fo...
GlobeNewswire
04-30
BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leade...
GlobeNewswire
04-29
BAORUI Applied New Security Measures to Protect Investors from Scams: Redefining Security in Crypto ...
GlobeNewswire
04-29
BAORUI Builds a Protection Ecosystem from Scams: the Comprehensive Security Strategy of BAORUI
GlobeNewswire
04-26
Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388...
GlobeNewswire
04-25
Initiative Equity Partners acquired 16% equity in ArtIn Energy ramping up expansion in North America
GlobeNewswire
04-25
Prime Video to Become the Home of National Monday Night NHL Games in Canada Beginning in 2024-25 Sea...
GlobeNewswire
04-25
Golden Triangle Ventures Announces Four-Pillar Business Model for Lavish Entertainment
GlobeNewswire
04-25
Hanryu Holdings, Inc. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
GlobeNewswire
04-24
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Priva...
GlobeNewswire
04-24
Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Cl...
GlobeNewswire
04-24
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 20...